-
UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Rating of "Buy" from Analysts
来源: Buzz FX / 19 2月 2025 01:36:11 America/Chicago
UroGen Pharma Ltd. (NASDAQ:URGN) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Shares of UroGen Pharma Ltd. ( NASDAQ:URGN - Get Free Report ) have been assigned an ave
Read more...